Doug O’Gorman

1.7k total citations · 1 hit paper
35 papers, 968 citations indexed

About

Doug O’Gorman is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Doug O’Gorman has authored 35 papers receiving a total of 968 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Surgery, 19 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Molecular Biology. Recurrent topics in Doug O’Gorman's work include Pancreatic function and diabetes (33 papers), Diabetes Management and Research (17 papers) and Cannabis and Cannabinoid Research (9 papers). Doug O’Gorman is often cited by papers focused on Pancreatic function and diabetes (33 papers), Diabetes Management and Research (17 papers) and Cannabis and Cannabinoid Research (9 papers). Doug O’Gorman collaborates with scholars based in Canada, Mexico and United States. Doug O’Gorman's co-authors include Tatsuya Kin, A. M. James Shapiro, Peter Senior, Sharleen Imes, Edmond A. Ryan, Rena Pawlick, A. M. James Shapiro, Abdul Salam, Patrick E. MacDonald and Jonathan R. T. Lakey and has published in prestigious journals such as Nature Communications, Diabetes and Annals of Surgery.

In The Last Decade

Doug O’Gorman

34 papers receiving 943 citations

Hit Papers

Pancreatic islet transplantation in type 1 diabetes: 20-y... 2022 2026 2023 2024 2022 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Doug O’Gorman Canada 17 891 506 409 240 219 35 968
Elsie Zahr United States 11 443 0.5× 214 0.4× 274 0.7× 97 0.4× 129 0.6× 15 564
Jeffrey D. Ansite United States 12 1.2k 1.3× 516 1.0× 703 1.7× 272 1.1× 195 0.9× 19 1.3k
Yasutaka Fujita Japan 15 508 0.6× 257 0.5× 226 0.6× 138 0.6× 114 0.5× 33 574
Jennifer Hollister United States 5 521 0.6× 208 0.4× 270 0.7× 138 0.6× 143 0.7× 7 542
Josué Kunjom Mfopou Belgium 15 624 0.7× 232 0.5× 267 0.7× 26 0.1× 483 2.2× 19 806
Aseda Tena United States 11 341 0.4× 29 0.1× 213 0.5× 32 0.1× 190 0.9× 19 487
Simone Giacometti United States 6 449 0.5× 191 0.4× 240 0.6× 27 0.1× 307 1.4× 6 644
Jonathan Shintaku United States 7 239 0.3× 65 0.1× 83 0.2× 51 0.2× 182 0.8× 9 383
Despina Agapitos Canada 9 374 0.4× 165 0.3× 171 0.4× 60 0.3× 150 0.7× 14 436

Countries citing papers authored by Doug O’Gorman

Since Specialization
Citations

This map shows the geographic impact of Doug O’Gorman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doug O’Gorman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doug O’Gorman more than expected).

Fields of papers citing papers by Doug O’Gorman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doug O’Gorman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doug O’Gorman. The network helps show where Doug O’Gorman may publish in the future.

Co-authorship network of co-authors of Doug O’Gorman

This figure shows the co-authorship network connecting the top 25 collaborators of Doug O’Gorman. A scholar is included among the top collaborators of Doug O’Gorman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doug O’Gorman. Doug O’Gorman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parente, Alessandro, Kevin Verhoeff, Tatsuya Kin, et al.. (2024). Evaluating Islet Cell Isolation and Transplantation From Donors Following Medical Assistance in Dying. Transplantation Direct. 10(7). e1667–e1667.
3.
Forbes, Shareen, Anne Halpin, Anna Lam, et al.. (2023). Islet transplantation outcomes in type 1 diabetes and transplantation of HLA-DQ8/DR4: results of a single-centre retrospective cohort in Canada. EClinicalMedicine. 67. 102333–102333. 4 indexed citations
4.
Verhoeff, Kevin, Nidheesh Dadheech, Tiffany Dang, et al.. (2023). Suspension culture improves iPSC expansion and pluripotency phenotype. Stem Cell Research & Therapy. 14(1). 154–154. 26 indexed citations
5.
Marfil‐Garza, Braulio A., Sharleen Imes, Kevin Verhoeff, et al.. (2022). Pancreatic islet transplantation in type 1 diabetes: 20-year experience from a single-centre cohort in Canada. The Lancet Diabetes & Endocrinology. 10(7). 519–532. 97 indexed citations breakdown →
6.
Ernst, Alexander U., Long‐Hai Wang, Scott C. Worland, et al.. (2022). A predictive computational platform for optimizing the design of bioartificial pancreas devices. Nature Communications. 13(1). 6031–6031. 17 indexed citations
7.
Pepper, Andrew R., Rena Pawlick, Antonio Bruni, et al.. (2017). Transplantation of Human Pancreatic Endoderm Cells Reverses Diabetes Post Transplantation in a Prevascularized Subcutaneous Site. Stem Cell Reports. 8(6). 1689–1700. 63 indexed citations
8.
Al‐Adra, David, Richdeep S. Gill, Sharleen Imes, et al.. (2014). Single-Donor Islet Transplantation and Long-term Insulin Independence in Select Patients With Type 1 Diabetes Mellitus. Transplantation. 98(9). 1007–1012. 47 indexed citations
9.
Pepper, Andrew R., Boris Gala-López, Rena Pawlick, et al.. (2014). Human Islet Viability and Function Is Maintained During High-density Shipment in Silicone Rubber Membrane Vessels. Transplantation Proceedings. 46(6). 1989–1991. 13 indexed citations
10.
O’Gorman, Doug, Tatsuya Kin, Angelika C. Gruessner, et al.. (2014). Islet Oxygen Consumption Rate Dose Predicts Insulin Independence for First Clinical Islet Allotransplants. Transplantation Proceedings. 46(6). 1985–1988. 24 indexed citations
11.
O’Gorman, Doug, Tatsuya Kin, Rena Pawlick, et al.. (2013). Clinical islet isolation outcomes with a highly purified neutral protease for pancreas dissociation. Islets. 5(3). 111–115. 13 indexed citations
12.
Gala-López, Boris, Tatsuya Kin, Doug O’Gorman, et al.. (2013). Microbial Contamination of Clinical Islet Transplant Preparations Is Associated with Very Low Risk of Infection. Diabetes Technology & Therapeutics. 15(4). 323–327. 23 indexed citations
13.
Kin, Tatsuya, Doug O’Gorman, Peter Senior, & AM James Shapiro. (2010). Experience of islet isolation without neutral protease supplementation. Islets. 2(5). 278–282. 12 indexed citations
14.
O’Gorman, Doug, Tatsuya Kin, Sharleen Imes, et al.. (2010). Comparison of Human Islet Isolation Outcomes Using a New Mammalian Tissue-Free Enzyme Versus Collagenase NB-1. Transplantation. 90(3). 255–259. 44 indexed citations
15.
Kin, Tatsuya, Doug O’Gorman, Rena Pawlick, et al.. (2009). Nonsimultaneous Administration of Pancreas Dissociation Enzymes During Islet Isolation. Transplantation. 87(11). 1700–1705. 19 indexed citations
16.
Kin, Tatsuya, et al.. (2008). Risk factors for islet loss during culture prior to transplantation. Transplant International. 21(11). 1029–35. 111 indexed citations
17.
Kin, Tatsuya, et al.. (2008). Detrimental effect of excessive collagenase class II on human islet isolation outcome. Transplant International. 21(11). ???–???. 18 indexed citations
18.
O’Gorman, Doug, Tatsuya Kin, Thaddeus J. T. Murdoch, et al.. (2005). The Standardization of Pancreatic Donors for Islet Isolation. Transplantation Proceedings. 37(2). 1309–1310. 63 indexed citations
19.
O’Gorman, Doug, et al.. (2005). Multi-lot Analysis of Custom Collagenase Enzyme Blend in Human Islet Isolations. Transplantation Proceedings. 37(8). 3417–3419. 12 indexed citations
20.
O’Gorman, Doug, Tatsuya Kin, Travis B. Murdoch, et al.. (2005). The Standardization of Pancreatic Donors for Islet Isolations. Transplantation. 80(6). 801–806. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026